Related references
Note: Only part of the references are listed.Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: A naturalistic 12-month follow-up study
Xiaofeng Guo et al.
NEUROSCIENCE LETTERS (2011)
Cognitive effects of six months of treatment with quetiapine in antipsychotic-naive first-episode schizophrenia
Rune Andersen et al.
PSYCHIATRY RESEARCH (2011)
Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis
David Baldwin et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone
M. Riedel et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)
Michael Davidson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis
Manuel J. Cuesta et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Neurocognitive Effectiveness of Haloperidol, Risperidone, and Olanzapine in First-Episode Psychosis: A Randomized, Controlled 1-Year Follow-Up Comparison
Benedicto Crespo-Facorro et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Longitudinal studies of cognition in schizophrenia: meta-analysis
Andrei Szoeke et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: A randomized, double-blind 52-week comparison
Richard S. E. Keefe et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
Richard S. E. Keefe et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: Dose effects and comparison to practice effects
Neil D. Woodward et al.
SCHIZOPHRENIA RESEARCH (2007)
The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review
Allen E. Thornton et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis
RSE Keefe et al.
BIOLOGICAL PSYCHIATRY (2006)
Defining a cognitive function decrement in schizophrenia
RSE Keefe et al.
BIOLOGICAL PSYCHIATRY (2005)
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
ND Woodward et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: A randomized, double-blind trial of olanzapine versus low doses of haloperidol
RSE Keefe et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: Opening a closed book
AL Mishara et al.
BIOLOGICAL PSYCHIATRY (2004)
Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia - A randomized controlled trial
R Rosenheck et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Network meta-analysis for indirect treatment comparisons
T Lumley
STATISTICS IN MEDICINE (2002)
Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates
RM Bilder et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol
SE Purdon et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the right stuff?
MF Green et al.
SCHIZOPHRENIA BULLETIN (2000)
Share Paper
